(Q70994774)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

1 reference

S ten Wolde

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

F C Breedveld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J Hermans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J P Vandenbroucke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M A van de Laar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

H M Markusse

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M Janssen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

H R van den Brink

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

B A Dijkmans

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

8998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

347-352

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

Chloroquine and hydroxychloroquine therapy in rheumatoid arthritis

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

A controlled trial of gold salt therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Efficacy of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Azathioprine in rheumatoid arthritis. A double-blind, cross over study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Clinical trial of penicillamine in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Rheumatoid arthritis: can the long-term outcome be altered?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Long-term second-line treatment: a prospective drug survival study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Outcome of second line therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Long-term azathioprine in rheumatoid arthritis: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Low dose, long-term treatment of rheumatoid arthritis with azathioprine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

D-penicillamine withdrawal in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Low-dose methotrexate in rheumatoid arthritis: effect and tolerance. An open trial and a double-blind randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

A multicentre1) controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

A double-blind study on the effect of discontinuation of gold therapy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Gold binding to blood cells and serum proteins during chrysotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Measurement of disability in Dutch rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Sulphasalazine in the long term management of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Second-line drug therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2990535-8

7 January 2021

10.1016/S0140-6736(96)90535-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8598699%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference